ACM Research (ACMR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Apr, 2026Executive summary
The 2026 Annual Meeting will be held virtually on June 10, 2026, allowing global shareholder participation and voting via webcast, phone, or mail.
Shareholders of record as of April 13, 2026, are eligible to vote on the election of four directors and the ratification of the independent auditor.
Proxy materials are distributed primarily via the Internet to reduce costs and environmental impact, with printed copies available upon request.
The board encourages shareholder engagement, including Q&A during the meeting and ongoing feedback initiatives.
Voting matters and shareholder proposals
Shareholders will vote on two proposals: (1) election of four directors and (2) ratification of Ernst & Young Hua Ming LLP as independent auditor for 2026.
Each Class A share has one vote; each Class B share has twenty votes per proposal, totaling 161,059,224 votes.
Shareholder proposals for the 2027 meeting must be submitted by December 31, 2026, for proxy inclusion.
Board of directors and corporate governance
The board consists of four nominees, three of whom are independent and three self-identify as diverse by gender or race.
Board committees include audit, compensation, and nominating/governance, each with independent members and defined charters.
The board meets at least four times annually, with all directors attending at least 75% of meetings in 2025.
The Chair of the Board and CEO roles are combined, with an independent Lead Director to ensure oversight.
Latest events from ACM Research
- 2025 revenue rose 15.2% to $901.3M, with expanding global reach and product innovation.ACMR
Investor presentation20 Mar 2026 - 2025 revenue hit $901.3M, with 2026 guidance for 21–30% growth despite margin pressure.ACMR
Q4 202526 Feb 2026 - Q2 revenue up 40% to $202.5M, margins strong, 2024 guidance raised, new products launched.ACMR
Q2 20242 Feb 2026 - Q3 revenue up 21% to $204M, margins strong, 2024 outlook raised, global expansion ongoing.ACMR
Q3 202416 Jan 2026 - Supply chain localization and product innovation drive growth amid export controls and market shifts.ACMR
UBS Global Technology and AI Conference11 Jan 2026 - 2024 revenue rose 40% to $782.1M, with strong margins and a robust 2025 outlook.ACMR
Q4 202423 Dec 2025 - Shareholders will elect four directors and ratify the auditor at a virtual 2025 annual meeting.ACMR
Proxy Filing1 Dec 2025 - Election of directors and auditor ratification to be decided at the June 2025 virtual meeting.ACMR
Proxy Filing1 Dec 2025 - Q1 2025 revenue up 13.2% year-over-year, with net income and cash rising but margin lower.ACMR
Q1 202525 Nov 2025